RT Journal Article
SR Electronic
T1 White blood cells and severe COVID-19: a Mendelian randomization study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.14.20212993
DO 10.1101/2020.10.14.20212993
A1 Sun, Yitang
A1 Zhou, Jingqi
A1 Ye, Kaixiong
YR 2020
UL http://medrxiv.org/content/early/2020/10/18/2020.10.14.20212993.abstract
AB Background The pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly emerged to seriously threaten public health. We aimed to investigate whether white blood cell traits have potential causal effects on severe COVID-19 using Mendelian randomization (MR).Methods To evaluate the causal associations between various white blood cell traits and severe COVID-19, we conducted a two-sample MR analysis with summary statistics from recent large genome-wide association studies.Results Our MR results indicated potential causal associations of white blood cell count, myeloid white blood cell count, and granulocyte count with severe COVID-19, with odds ratios (OR) of 0.84 (95% CI: 0.72-0.98), 0.81 (95% CI: 0.70-0.94), and 0.84 (95% CI: 0.71-0.99), respectively. Increasing eosinophil percentage of white blood cells was associated with a higher risk of severe COVID-19 (OR: 1.22, 95% CI: 1.03-1.45).Conclusions Our results suggest the potential causal effects of lower white blood cell count, lower myeloid white blood cell count, lower granulocyte count, and higher eosinophil percentage of white blood cells on an increased risk of severe COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementKY is supported by the University of Georgia Research Foundation. Funding sources had no involvement in the conception, design, analysis, or presentation of this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study does not analyze individual-level data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated or analyzed during this study are included in this published article and this supplementary information files.COVID-19coronavirus disease 2019SARS-CoV-2severe acute respiratory syndrome coronavirus 2MRMendelian randomizationGWASgenome-wide association studiesSNPssingle nucleotide polymorphismsLDlinkage disequilibriumHGIHost Genetics InitiativeIEUIntegrative Epidemiology UnitIVWinverse variance-weightedWMweighted medianMR-PRESSOMendelian randomization pleiotropy residual sum and outlier